Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02229149
Title Phase 2 Study of Standard Chemotherapy With Trastuzumab, Plus or Minus Pertuzumab, for Pre-treated Metastatic Breast Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors US Oncology Research
Indications

Her2-receptor positive breast cancer

Therapies

Paclitaxel

Docetaxel

Pertuzumab + Trastuzumab

Nab-paclitaxel

Vinorelbine

Trastuzumab

Capecitabine

Age Groups: adult
Covered Countries USA


No variant requirements are available.